121 related articles for article (PubMed ID: 40390)
1. Mutagenic activation of tris(2,3-dibromopropyl)phosphate: the role of microsomal oxidative metabolism.
Søderlund EJ; Nelson SD; Dybing E
Acta Pharmacol Toxicol (Copenh); 1979 Aug; 45(2):112-21. PubMed ID: 40390
[TBL] [Abstract][Full Text] [Related]
2. Metabolism in vitro of tris(2,3-dibromopropyl)-phosphate: oxidative debromination and bis(2,3-dibromopropyl)phosphate formation as correlates of mutagenicity and covalent protein binding.
Søderlund EJ; Gordon WP; Nelson SD; Omichinski JG; Dybing E
Biochem Pharmacol; 1984 Dec; 33(24):4017-23. PubMed ID: 6508849
[TBL] [Abstract][Full Text] [Related]
3. Comparative genotoxicity studies of the flame retardant tris(2,3-dibromopropyl)phosphate and possible metabolites.
Holme JA; Søderlund EJ; Hongslo JK; Nelson SD; Dybing E
Mutat Res; 1983 Dec; 124(3-4):213-24. PubMed ID: 6686285
[TBL] [Abstract][Full Text] [Related]
4. Activation mechanism of tris(2,3-dibromopropyl)phosphate to the potent mutagen, 2-bromoacrolein.
Nelson SD; Omichinski JG; Iyer L; Gordon WP; Soderlund EJ; Dybing E
Biochem Biophys Res Commun; 1984 May; 121(1):213-9. PubMed ID: 6375666
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and mutagenicity of selectively methylated analogs of tris(2,3-dibromopropyl)phosphate and 1,2-dibromo-3-chloropropane.
Omichinski JG; Søderlund EJ; Bausano JA; Dybing E; Nelson SD
Mutagenesis; 1987 Jul; 2(4):287-92. PubMed ID: 3325760
[TBL] [Abstract][Full Text] [Related]
6. Comparative genotoxicity and nephrotoxicity studies of the two halogenated flame retardants tris(1,3-dichloro-2-propyl)phosphate and tris(2,3-dibromopropyl)phosphate.
Søderlund EJ; Dybing E; Holme JA; Hongslo JK; Rivedal E; Sanner T; Nelson SD
Acta Pharmacol Toxicol (Copenh); 1985 Jan; 56(1):20-9. PubMed ID: 3883695
[TBL] [Abstract][Full Text] [Related]
7. Increased mutagenicity of 1,2-dibromo-3-chloropropane and tris(2,3-dibromopropyl)phosphate in Salmonella TA100 expressing human glutathione S-transferases.
Simula TP; Glancey MJ; Söderlund EJ; Dybing E; Wolf CR
Carcinogenesis; 1993 Nov; 14(11):2303-7. PubMed ID: 8242859
[TBL] [Abstract][Full Text] [Related]
8. Mutagenicity of bis- and mono-(2,3-dibromopropyl)phosphate, and their salts used as flame retardants, in the Salmonella/microsome system.
Nakamura A; Tateno N; Iwata T; Kojima S; Kaniwa M; Kawamura T
Mutat Res; 1983 Apr; 117(1-2):1-8. PubMed ID: 6339901
[TBL] [Abstract][Full Text] [Related]
9. Tris(2,3-dibromopropyl) phosphate: mutagenicity of a widely used flame retardant.
Prival MJ; McCoy EC; Gutter B; Rosendranz HS
Science; 1977 Jan; 195(4273):76-8. PubMed ID: 318761
[TBL] [Abstract][Full Text] [Related]
10. Lack of mammalian mutagenicity of the potent bacterial mutagen tris(2,3-dibromopropyl) phosphate and its metabolite 2-bromoacrolein.
van Beerendonk GJ; Klein JC; Tijdens RB; Lichtenauer-Kaligis EG; Tasseron-de Jong JG; Meerman JH
Mutat Res; 1998 Jul; 415(3):201-11. PubMed ID: 9714806
[TBL] [Abstract][Full Text] [Related]
11. Another flame retardant, tris-(1,3-dichloro-2-propyl)-phosphate, and its expected metabolites are mutagens.
Gold MD; Blum A; Ames BN
Science; 1978 May; 200(4343):785-7. PubMed ID: 347576
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo covalent binding of the kidney toxicant and carcinogen tris(2,3-dibromopropyl)-phosphate.
Söderlund EJ; Nelson SD; Dybing E
Toxicology; 1981; 21(4):291-304. PubMed ID: 7302950
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity studies on the mutagenicity of tris(2,3-dibromopropyl) phosphate (Tris-BP) and its metabolites in Salmonella.
Zeiger E; Pagano DA; Nomeir AA
Environ Mutagen; 1982; 4(3):271-7. PubMed ID: 7094911
[TBL] [Abstract][Full Text] [Related]
14. Mutagenicity of Tris(2,3-dibromopropyl) phosphate in mammalian gonad and bone marrow tissue.
Salamone MF; Katz M
J Natl Cancer Inst; 1981 Apr; 66(4):691-5. PubMed ID: 6939915
[TBL] [Abstract][Full Text] [Related]
15. A new mutagenic and genotoxic response of the flame retardant tris(2,3-dibromopropyl)phosphate. Activation by singlet oxygen.
McCoy E; Hyman J; Rosenkranz HS
Mutat Res; 1980 Mar; 77(3):209-14. PubMed ID: 6991918
[TBL] [Abstract][Full Text] [Related]
16. Disposition of the flame retardant, tris(1,3-dichloro-2-propyl) phosphate, in the rat.
Lynn RK; Wong K; Garvie-Gould C; Kennish JM
Drug Metab Dispos; 1981; 9(5):434-41. PubMed ID: 6117442
[TBL] [Abstract][Full Text] [Related]
17. Irreversible macromolecular binding of the flame retardant tris-(2, 3-dibromopropyl)phosphate in vitro and in vivo.
Dybing E; Söderlund EJ; Nelson SD
Dev Toxicol Environ Sci; 1980; 8():265-8. PubMed ID: 7308025
[No Abstract] [Full Text] [Related]
18. Metabolism, distribution, and excretion of the flame retardant, tris(2,3-dibromopropyl) phosphate (tris-bp) in the rat: identification of mutagenic and nephrotoxic metabolites.
Lynn RK; Garvie-Gould C; Wong K; Kennish JM
Toxicol Appl Pharmacol; 1982 Mar; 63(1):105-19. PubMed ID: 7071866
[No Abstract] [Full Text] [Related]
19. Children absorb tris-BP flame retardant from sleepwear: urine contains the mutagenic metabolite, 2,3-dibromopropanol.
Blum A; Gold MD; Ames BN; Jones FR; Hett EA; Dougherty RC; Horning EC; Dzidic I; Carroll DI; Stillwell RN; Thenot JP
Science; 1978 Sep; 201(4360):1020-3. PubMed ID: 684422
[TBL] [Abstract][Full Text] [Related]
20. Metabolic activation of tris(2,3-dibromopropyl)phosphate to reactive intermediates. I. Covalent binding and reactive metabolite formation in vitro.
Pearson PG; Omichinski JG; McClanahan RH; Søderlund EJ; Dybing E; Nelson SD
Toxicol Appl Pharmacol; 1993 Feb; 118(2):186-95. PubMed ID: 8441997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
